These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31352420)

  • 1. Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis.
    Zeng H; Luo M; Li Z; Wen J; He G; Jin Y; Fu W; Zhou P
    BMJ Open; 2019 Jul; 9(7):e029426. PubMed ID: 31352420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
    Bohula EA; Scirica BM; Inzucchi SE; McGuire DK; Keech AC; Smith SR; Kanevsky E; Murphy SA; Leiter LA; Dwyer JP; Corbalan R; Hamm C; Kaplan L; Nicolau JC; Ophuis TO; Ray KK; Ruda M; Spinar J; Patel T; Miao W; Perdomo C; Francis B; Dhadda S; Bonaca MP; Ruff CT; Sabatine MS; Wiviott SD;
    Lancet; 2018 Nov; 392(10161):2269-2279. PubMed ID: 30293771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis.
    Yang W; Wen J; Wu F; Zeng H; Guo B; Ge L
    Medicine (Baltimore); 2021 Mar; 100(11):e24812. PubMed ID: 33725948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative long-term effectiveness and safety of primary bariatric surgeries in treating type 2 diabetes mellitus in adults: a protocol for systematic review and network meta-analysis of randomised controlled trials.
    Ding L; Zhuo C; Fan Y; Zhang Y; Li H; Qi D; Tang S; Cui J; He Q; Liu M
    BMJ Open; 2019 Apr; 9(4):e028430. PubMed ID: 30948619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
    Bohula EA; Scirica BM; Fanola C; Inzucchi SE; Keech A; McGuire DK; Smith SR; Abrahamsen T; Francis BH; Miao W; Perdomo CA; Satlin A; Wiviott SD; Sabatine MS
    Am Heart J; 2018 Aug; 202():39-48. PubMed ID: 29803985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol.
    Wang X; Liu J; Huang L; Zeng H; He G; Chen L; Ma R; Fu W; Ning B
    BMJ Open; 2019 Oct; 9(10):e029073. PubMed ID: 31594873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    Bohula EA; Wiviott SD; McGuire DK; Inzucchi SE; Kuder J; Im K; Fanola CL; Qamar A; Brown C; Budaj A; Garcia-Castillo A; Gupta M; Leiter LA; Weissman NJ; White HD; Patel T; Francis B; Miao W; Perdomo C; Dhadda S; Bonaca MP; Ruff CT; Keech AC; Smith SR; Sabatine MS; Scirica BM;
    N Engl J Med; 2018 Sep; 379(12):1107-1117. PubMed ID: 30145941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of yoga to prevent diabetes mellitus type 2: A protocol for systematic review and meta-analysis.
    Ramamoorthi R; Gahreman D; Moss S; Skinner T
    Medicine (Baltimore); 2019 Jan; 98(3):e14019. PubMed ID: 30653107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lorcaserin on progression of prediabetes to type 2 diabetes and reversion to euglycemia.
    Nesto R; Fain R; Li Y; Shanahan W
    Postgrad Med; 2016 May; 128(4):364-70. PubMed ID: 27116910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lorcaserin on cardiometabolic risk factors in overweight and obese patients: A systematic review and meta-analysis.
    Kuo HH; Wang KT; Lee YH; Lin PL; Liu ME; Lin CY; Liu LY
    J Clin Pharm Ther; 2020 Feb; 45(1):35-44. PubMed ID: 31544267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability review of lorcaserin in clinical trials.
    Greenway FL; Shanahan W; Fain R; Ma T; Rubino D
    Clin Obes; 2016 Oct; 6(5):285-95. PubMed ID: 27627785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of strategies for nutritional therapy for patients with type 2 diabetes and/or hypertension in primary care: protocol of a systematic review of randomised controlled trials.
    Simões Corrêa Galendi J; Leite RGOF; Mendes AL; Nunes-Nogueira VDS
    BMJ Open; 2019 Sep; 9(9):e030450. PubMed ID: 31488489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders.
    Pi-Sunyer X; Shanahan W; Fain R; Ma T; Garvey WT
    Postgrad Med; 2016 Aug; 128(6):591-7. PubMed ID: 27389084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorcaserin: an investigational serotonin 2C agonist for weight loss.
    Hurren KM; Berlie HD
    Am J Health Syst Pharm; 2011 Nov; 68(21):2029-37. PubMed ID: 22011982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight loss.
    Handelsman Y; Fain R; Wang Z; Li X; Fujioka K; Shanahan W
    Postgrad Med; 2016 Nov; 128(8):740-746. PubMed ID: 27659698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
    Fidler MC; Sanchez M; Raether B; Weissman NJ; Smith SR; Shanahan WR; Anderson CM;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3067-77. PubMed ID: 21795446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM-DM studies.
    Apovian C; Palmer K; Fain R; Perdomo C; Rubino D
    Diabetes Obes Metab; 2016 Sep; 18(9):945-8. PubMed ID: 27173586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise and adiposity in overweight and obese children and adolescents: protocol for a systematic review and network meta-analysis of randomised trials.
    Kelley GA; Kelley KS; Pate RR
    BMJ Open; 2017 Dec; 7(12):e019512. PubMed ID: 29288191
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.